XFLH Capital Corporation primarily seeks to execute various forms of business combinations, including mergers, exchanges of shares, asset acquisitions, share purchases, and corporate reorganizations. The firm was established in 2025 and is headquartered in Dover, Delaware.
XFLH Capital Corporation Announces the Signing of a Letter of Intent with Renogen Biolab Inc.
XFLH Capital Corporation, a Cayman Islands blank-check company, has signed a non-binding letter of intent for a business combination with Renogen Biolab Inc.
Renogen is a Canadian health service provider offering core molecular capabilities including DNA services, vector engineering, and protein expression.
Under the LOI, both parties will negotiate definitive agreements and grant each other due diligence access, but no deal value, exchange ratio, or financing terms were disclosed, leaving meaningful execution risk.